IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $814,000 | -28.2% | 616,355 | 0.0% | 0.03% | -31.2% |
Q1 2018 | $1,134,000 | -12.8% | 616,355 | 0.0% | 0.05% | -14.3% |
Q4 2017 | $1,301,000 | -5.3% | 616,355 | 0.0% | 0.06% | -3.4% |
Q3 2017 | $1,374,000 | +29.6% | 616,355 | 0.0% | 0.06% | +18.4% |
Q2 2017 | $1,060,000 | -30.4% | 616,355 | 0.0% | 0.05% | -31.9% |
Q1 2017 | $1,522,000 | +64.5% | 616,355 | 0.0% | 0.07% | +35.8% |
Q4 2016 | $925,000 | -71.3% | 616,355 | -51.0% | 0.05% | -71.7% |
Q3 2016 | $3,220,000 | +67.4% | 1,257,748 | 0.0% | 0.19% | +29.0% |
Q2 2016 | $1,924,000 | -22.7% | 1,257,748 | 0.0% | 0.14% | -24.9% |
Q1 2016 | $2,490,000 | -35.9% | 1,257,748 | 0.0% | 0.19% | -10.6% |
Q4 2015 | $3,886,000 | -7.8% | 1,257,748 | 0.0% | 0.22% | +6.4% |
Q3 2015 | $4,213,000 | -7.4% | 1,257,748 | +2.5% | 0.20% | +0.5% |
Q2 2015 | $4,551,000 | +4.8% | 1,226,748 | +4.8% | 0.20% | -6.0% |
Q1 2015 | $4,342,000 | – | 1,170,248 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |